Skip to content
Text “Loti” to 833-962-6682 to join the Loti Labs VIP Group!
Loti Labs Resources Blog

Klow Blend: Four-Peptide Research Formulation Guide (GHK-Cu, BPC-157, TB-500, KPV)

What Is the Klow Blend?

Klow Blend is a lyophilized four-peptide research formulation combining GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) in a single 80mg vial. Researchers studying multi-pathway interventions in preclinical models use this type of combination formulation to examine whether synergistic activity is achievable across these overlapping systems.

Component Research Overview

GHK-Cu (Copper Peptide) : 50mg

BPC-157 (Body Protection Compound) : 10mg

BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric protein sequence.

TB-500 (Thymosin Beta-4 Analog) : 10mg

TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide involved in actin regulation and cell motility.

KPV (Lys-Pro-Val) : 10mg

KPV is a tripeptide fragment (Lys-Pro-Val) derived from the C-terminal sequence of alpha-melanocyte stimulating hormone (α-MSH).

Rationale for Four-Component Combination

GHK-Cu50mg
BPC-15710mg
TB-50010mg
KPV10mg

Because the Klow Blend contains four components at fixed ratios, researchers work with the combined 80mg total when calculating molarity or mg/mL concentration : not the individual peptide masses.

Frequently Asked Questions

What is Klow Blend used for in research?

The blend allows researchers to study the combined activity of these peptides in a single formulation.

How does Klow Blend differ from BPC-157 and TB-500 alone?

This creates a four-pathway model not covered by the BPC-157/TB-500 pairing alone.

What is KPV and why is it included in Klow Blend?

KPV (Lys-Pro-Val) is a tripeptide derived from alpha-MSH.

Is there clinical data on the Klow Blend combination?

No human clinical trial data exists for the Klow Blend as a combined formulation. Each individual component has its own preclinical data profile. GHK-Cu and BPC-157 have the most extensive preclinical literature; TB-500 and KPV have more limited but growing research bases. All research on Klow Blend and its components remains at the preclinical stage.


Research-Grade Klow Blend at Loti Labs

Loti Labs supplies Klow Blend 80mg : a four-peptide research formulation combining GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg : for preclinical and in vitro laboratory research. Each batch is independently verified by third-party HPLC analysis. Supplied for research use only.

Research-use notice

This educational material discusses laboratory research concepts only. Loti Labs products are intended strictly for research and development use and are not for human consumption.

Ready to explore?

Browse high-purity research materials by format or view the full catalog.